February 27, 2019
2 min watch
Save
This article is more than 5 years old. Information may no longer be current.
VIDEO: J&J lowers Lipiflow activator price to improve access to technology
NEW ORLEANS – Joseph Boorady, OD, FAAO, vice president of ocular surface for Johnson & Johnson Vision, announced a price cut on the activators for its Lipiflow device.
“Our hope is that this lower activator cost makes the Lipiflow MGD [meibomian gland dysfunction] treatment more accessible and lays the foundation for changing the standard of care for MGD,” he said.
Boorady also shared positive clinical study results for the technology.